| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/05/2011 | EP2270188A2 Defensin polynucleotides and methods of use |
| 01/05/2011 | EP2270187A2 Defensin polynucleotides and methods of use |
| 01/05/2011 | EP2270186A2 Defensin polynucleotides and methods of use |
| 01/05/2011 | EP2270185A2 Defensin polynucleotides and methods of use |
| 01/05/2011 | EP2270184A2 Defensin polynucleotides and methods of use |
| 01/05/2011 | EP2270183A2 Down-regulation of gene expression using artificial microRNAs |
| 01/05/2011 | EP2270182A2 DSRNA as insect control agent |
| 01/05/2011 | EP2270181A2 DSRNA as insect control agent |
| 01/05/2011 | EP2270180A2 DNA cloning vector plasmids and methods for their use |
| 01/05/2011 | EP2270178A2 Method for producing alcohol and carboxylic acid having optical activity |
| 01/05/2011 | EP2270177A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270176A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270175A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270174A1 Combination neisserial compositions |
| 01/05/2011 | EP2270173A1 Combination neisserial compositions |
| 01/05/2011 | EP2270172A1 Combination neisserial compositions |
| 01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/05/2011 | EP2270169A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 01/05/2011 | EP2270168A1 Mutant gene capable of controlling the oil-and-fat content in seed, and method for controlling the oil-and-fat content in seed |
| 01/05/2011 | EP2270167A2 Polynucleotides and polypeptides in plants |
| 01/05/2011 | EP2270166A2 Polynucleotides and polypeptides in plants |
| 01/05/2011 | EP2270165A2 Defensin polynucleotides and methods of use |
| 01/05/2011 | EP2270164A2 Recombinant protein variants |
| 01/05/2011 | EP2270163A1 Muteins of fibroblast growth factor 21 |
| 01/05/2011 | EP2270162A2 Conserved HBV and HCV sequences useful for gene silencing |
| 01/05/2011 | EP2270161A2 Multiple RNA polymerase III promoter expression constructs |
| 01/05/2011 | EP2270160A1 Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/05/2011 | EP2270159A1 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 01/05/2011 | EP2270158A2 Bitter taste receptors |
| 01/05/2011 | EP2270157A2 Bitter taste receptors |
| 01/05/2011 | EP2270156A2 Bitter taste receptors |
| 01/05/2011 | EP2270155A2 Bitter taste receptors |
| 01/05/2011 | EP2270154A2 Bitter taste receptors |
| 01/05/2011 | EP2270153A2 Bitter taste receptors |
| 01/05/2011 | EP2270152A1 Expression system using mammalian beta-actin promoter |
| 01/05/2011 | EP2270151A1 Method for removing paraffin from biological samples |
| 01/05/2011 | EP2270150A2 Method for controlling the activity of immunologically functional molecule |
| 01/05/2011 | EP2270149A2 Method for controlling the activity of immunologically functional molecule |
| 01/05/2011 | EP2270148A2 Method for controlling the activity of immunologically functional molecule |
| 01/05/2011 | EP2270147A2 Method for controlling the activity of immunologically functional molecule |
| 01/05/2011 | EP2270146A1 Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene |
| 01/05/2011 | EP2270145A1 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same |
| 01/05/2011 | EP2270144A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof |
| 01/05/2011 | EP2270143A1 Method of gene transfer into cells using electrospray and apparatus therefor |
| 01/05/2011 | EP2270142A1 Method of preparing dna fragment having sticky end |
| 01/05/2011 | EP2270141A1 Partial peptide of lacritin |
| 01/05/2011 | EP2270140A2 Variant lipolytic enzymes |
| 01/05/2011 | EP2270139A2 Variant lipolytic enzymes |
| 01/05/2011 | EP2270137A1 Method for producing cells having characteristic of hematopoietic stem cells/progenitor cells |
| 01/05/2011 | EP2270136A1 Compositions for bacterial mediated gene silencing and methods of using same |
| 01/05/2011 | EP2270135A1 Genetically modified coryneform bacteria capable of producing isopropanol |
| 01/05/2011 | EP2270055A2 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
| 01/05/2011 | EP2270053A1 Humanized AXL antibodies |
| 01/05/2011 | EP2270052A2 Antibodies to OPGL |
| 01/05/2011 | EP2270051A2 Antibody specific for human PD-1 and CD3 |
| 01/05/2011 | EP2270050A1 Anti-CD19 antibodies with reduced immunogenicity |
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270047A2 Anti-C5 antibodies and their therapeutic uses |
| 01/05/2011 | EP2270046A2 Methods and compositions for the treatment of hemolysis-associated diseases |
| 01/05/2011 | EP2270045A1 Antibodies against Clostridium difficile toxins and uses thereof |
| 01/05/2011 | EP2270042A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270041A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270040A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 01/05/2011 | EP2270037A2 Hasylated Factor IX |
| 01/05/2011 | EP2270036A2 Hasylated polypeptides |
| 01/05/2011 | EP2270034A2 Agents and methods for diagnosing stress |
| 01/05/2011 | EP2270032A2 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeenis |
| 01/05/2011 | EP2270031A2 Heterologous expression of neisserial proteins |
| 01/05/2011 | EP2270030A2 Heterologous expression of Neisserial proteins |
| 01/05/2011 | EP2270029A1 E.coli secretion system on the basis of S-layer proteins |
| 01/05/2011 | EP2270027A1 Polypeptides having brain-localizing activity and uses thereof |
| 01/05/2011 | EP2270024A1 Antisense modulation of superoxide dismutase 1, soluble expression |
| 01/05/2011 | EP2270015A1 Rna-selective hybridization reagent and utilization of the same |
| 01/05/2011 | EP2269972A1 Oviedomycin derivatives, method for obtaining same and use thereof |
| 01/05/2011 | EP2269658A1 Gene therapy for neurometabolic disorders |
| 01/05/2011 | EP2269634A2 Antigenic polypeptides |
| 01/05/2011 | EP2269628A2 Pancreas-specific proteins |
| 01/05/2011 | EP2269619A1 Methods and compositions concerning poxviruses and cancer |
| 01/05/2011 | EP2269618A1 An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer. |
| 01/05/2011 | EP2269444A2 DSRNA as insect control agent |
| 01/05/2011 | EP2269031A1 Use of disk surface for electroporation of adherent cells |
| 01/05/2011 | EP2268834A2 Expression-linked gene discovery |
| 01/05/2011 | EP2268828A2 Producing biofuels using polyketide synthases |
| 01/05/2011 | EP2268821A1 Abi1/hssh3bp1 conditional knockout mouse |
| 01/05/2011 | EP2268820A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/05/2011 | EP2268819A2 Method for creating broad-spectrum resistance to fungi in transgenic plants |
| 01/05/2011 | EP2268818A1 Expression system for proteins |
| 01/05/2011 | EP2268817A2 Variation of recombinant expression titres by optimising bacterial ribosome binding sites |
| 01/05/2011 | EP2268816A1 Polynucleotides and chimaera polypeptides for releasing a polypeptide of interest combined with exosomes and use thereof for the production of immunogenic compositions |
| 01/05/2011 | EP2268815A1 New mutated hydroxyphenylpyruvate dioxygenase, dna sequence and isolation of plants which are tolerant to hppd inhibitor herbicides |
| 01/05/2011 | EP2268814A1 Compositions and methods related to silicon transport |
| 01/05/2011 | EP2268813A1 Rna molecules and uses thereof |
| 01/05/2011 | EP2268812A1 Inhibitors of stim1 for the treatment of cardiovascular disorders |
| 01/05/2011 | EP2268811A1 Pharmaceutical compositions for treatment of microrna related diseases |
| 01/05/2011 | EP2268810A2 Method of modifying target region in host dna and selectable marker cassette |
| 01/05/2011 | EP2268809A1 Method of nuclear reprogramming |
| 01/05/2011 | EP2268808A1 Genome-wide construction of schizosaccharomyces pombe heterozygous deletion mutants containing gene-specific barcodes by the methods of 4-round serial or block pcr, or total gene synthesis thereof |
| 01/05/2011 | EP2268801A2 Compositions and processes relating to human bocavirus |
| 01/05/2011 | EP2268800A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs |